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Abstract  23 
 24 
Seafood intake in pregnancy has been positively associated with childhood cognitive outcomes 25 
which could potentially relate to the high vitamin-D content of oily fish. However, whether higher 26 
maternal vitamin D status [serum 25-hydroxy-vitamin D, 25(OH)D] in pregnancy is associated with 27 
a reduced risk of offspring suboptimal neurodevelopmental outcomes is unclear. A total of 7065 28 
mother-child pairs were studied from the Avon Longitudinal Study of Parents and Children 29 
(ALSPAC) cohort who had data for both serum total 25(OH)D concentration in pregnancy and at 30 
least one measure of offspring neurodevelopment (pre-school development at 6–42 months; 31 
“Strengths and Difficulties Questionnaire” scores at 7 years; IQ at 8 years; reading ability at 9 32 
years). After adjustment for confounders, children of vitamin-D deficient mothers (< 50.0 nmol/L) 33 
were more likely to have scores in the lowest quartile for gross motor development at 30 months 34 
(OR 1.20 95% CI 1.03, 1.40), fine motor development at 30 months (OR 1.23 95% CI 1.05, 1.44), 35 
and social development at 42 months (OR 1.20 95% CI 1.01, 1.41) than vitamin-D sufficient 36 
mothers (≥ 50.0 nmol/L).  No associations were found with neurodevelopmental outcomes, 37 
including IQ, measured at older ages. However, our results suggest that deficient maternal vitamin 38 
D status in pregnancy may have adverse effects on some measures of motor and social development 39 
in children under 4 years. Prevention of vitamin D deficiency may be important for preventing 40 
suboptimal development in the first 4 years of life.  41 
 42 
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Introduction  44 
The consumption of fish, or nutrients present in fish, by pregnant women has been linked to 45 
neurocognitive development in their children. In observational studies, maternal intake of fish or 46 
seafood in pregnancy has been positively associated with cognitive scores in the offspring(1; 2; 3; 4), 47 
while children whose mothers had eaten oily fish in early pregnancy had a reduced risk of 48 
hyperactivity than those whose mothers did not eat oily fish(3). While these studies tended to 49 
interpret these associations as effects of of long-chain omega-3 fatty acids, they might also be 50 
explained by the fact that oily fish is the best dietary source of vitamin D. Though the action of 51 
sunlight on the skin is the predominant  contributor to vitamin D status, dietary vitamin D can play 52 
an important role in determining status, as measured by the vitamin D metabolite, 25-53 
hydroxyvitamin D [25(OH)D]1, in serum or plasma(5).   Dietary sources of vitamin D (especially 54 
oily fish) are particularly important during the winter months when endogenous production of 55 
vitamin D status is limited. 56 
 57 
It is biologically plausible that vitamin D status in pregnant mothers may affect child 58 
neurocognitive development as vitamin D receptors are present in the brain(6)  and maternal vitamin 59 
D deficiency is known to be associated with abnormal brain development in the young rat(7).  In the 60 
period from birth to weaning in rats, there appears to be a window during which maternal vitamin D 61 
status affects offspring brain development(8) and these developmental changes may not occur if 62 
vitamin D is withheld until weaning(9).  Furthermore, vitamin D deficiency in late gestation can lead 63 
to impaired brain function in adult rats(8).  Due to differences between rat and human developmental 64 
physiology, the extent to which these findings would apply to humans remains unclear. 65 
 66 
Few human studies have assessed the relationship between maternal vitamin D status and 67 
neurodevelopmental outcomes.  The results of the five published observational studies that exist are 68 
inconsistent(10; 11; 12; 13; 14). Indeed, this fact was recently highlighted in the report from Public Health 69 
England on Vitamin D and Health from the Scientific Advisory Committee for Nutrition (SACN) 70 
(15).  71 
 72 
To address this lack of consistent evidence with respect to the association between maternal vitamin 73 
D status and cognitive-developmental outcomes in the offspring, we analysed data from the Avon 74 
Longitudinal Study of Parents and Children (ALSPAC) cohort.  Our a priori hypothesis was that 75 
poorer maternal vitamin D status, as measured by serum 25(OH)D, would be associated with 76 
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increased probability of suboptimal cognitive or behavioural development scores in childhood of 6 77 
months to 9 years. 78 
Subjects and Methods  79 
 80 
Study Design and Participants 81 
Details of ALSPAC methods have been detailed previously (16). In brief, all pregnant women living 82 
in the former Avon area in southwest England, who had an expected delivery date between April 1st 83 
1991 and December 31st 1992 were eligible for inclusion.  A total of 14,541 women were recruited, 84 
and there were 13,617 mother-child pairs with singleton offspring alive at one year.  The ALSPAC 85 
study website contains details of all the data that are available through a fully searchable data 86 
dictionary (http://www.bris.ac.uk/alspac/). Our study sample consisted of mother-child pairs that 87 
had both a serum 25(OH)D measure in pregnancy and at least one neurodevelopmental outcome of 88 
interest from 6 months to 9 years (Figure 1).  A range of outcomes was explored, including motor 89 
development, communication and social skills, behaviour, cognition and reading ability. 90 
 91 
Outcomes 92 
The ALSPAC pre-school development tests, which were based on questionnaires completed by the 93 
mother when the child was between 6 and 42 months of age, provided scores for four domains: fine 94 
motor, gross motor, social development, and communication (details published previously(1)). The 95 
Strengths and Difficulties Questionnaire (SDQ)(17) was completed by mothers when the child was 96 
81 months of age and was used to assess behavioural development. Intelligence Quotient (IQ) at age 97 
8 years had been assessed in the ALSPAC clinic using the abbreviated form of the Wechsler 98 
Intelligence Scale for Children, as previously described (1). Reading ability (accuracy, 99 
comprehension and speed) was assessed at age 9 years by trained psychologists using the Neale 100 
Analysis of Reading Ability(18) and by asking children to read real words to derive a reading score. 101 
Further details of these outcomes are available in the Supplementary File.   102 
 103 
Maternal vitamin D status 104 
Although 25(OH)D has lower biological activity than the active vitamin D hormone, 1,25-105 
dihydroxyvitamin D [1,25(OH)2D], serum/plasma 25(OH)D  is  widely regarded as the most 106 
reliable marker of vitamin D status(19).  Total maternal serum 25(OH)D concentration (including 107 
both vitamin D2 and vitamin D3) in ALSPAC mothers had been measured in a previous study by 108 
high-performance liquid chromatography and tandem mass-spectrometry, in accordance with 109 
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Vitamin D External Quality Assessment Scheme (DEQAS) requirements; full details have been 110 
published previously(20), including details of inter-assay coefficients of variation(21). 111 
 112 
Statistical analysis  113 
The women with vitamin D measurements were compared to the remaining ALSPAC women. We 114 
compared categorical variables with χ2 tests and continuous variables with independent t-tests. We 115 
used median (IQR, Inter-quartile Range) to describe maternal vitamin D status. Our main analysis 116 
dichotomised women as deficient or sufficient using 25(OH)D concentration  ≤ 50.0 nmol/L as the 117 
cut-off for vitamin D deficiency, as in previous ALSPAC work(20). We did additional 118 
supplementary analyses by dividing women into three categories (< 25.0, 25.0–49.9 and ≥ 50.0 119 
nmol/L) to explore the dose-response relationship.  120 
 121 
We used logistic regression to examine the relationship between maternal vitamin D status in 122 
pregnancy and odds of suboptimal development with the women in the vitamin-D-sufficient group 123 
(> 50.0 nmol/L) as the reference category.  We did not input missing confounder or outcome data 124 
with replacement values. We defined suboptimal development as scores in the lowest quartile for all 125 
subscales of early development, IQ and reading ability, as in previous ALSPAC research (1; 22). For 126 
the SDQ, suboptimal behaviour was defined according to published cut-offs (for both the individual 127 
scales and overall score) that indicate borderline/abnormal behaviour (17) (see Supplementary File 128 
Study Outcomes).   Model predictors were assessed for potential multicollinearity. For our final 129 
model, variance inflation factor ranged from 1.02 to 2.2 (accordingly tolerance ranged from 0.5-130 
0.99) depending on the variable.  131 
  132 
As vitamin D status and childhood cognitive and behavioural development are affected by a range 133 
of factors(23; 24), we included potential confounders in our analysis. The confounders chosen were 134 
based on previous ALSPAC findings(1; 22) and were from questionnaire and clinic-based data (Table 135 
1).  We included ten categorical and two continuous variables. The two continuous variables were 136 
maternal age (years), and maternal body mass index (BMI, Kg/m2). As there is a well-established 137 
relationship between BMI and 25(OH)D concentration(25), maternal BMI was included in the model, 138 
even though it was not statistically associated with 25(OH)D in this dataset (Table 1).  139 
 140 
The ten categorical variables comprised three groups: (i) child factors [gender and breastfeeding 141 
(none or some)], (ii) maternal factors [ethnicity (white or non-white), tobacco use in the first 142 
trimester (smoker or non-smoker), parity (zero, one or more) and oily fish intake in pregnancy 143 
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(never/rarely or once a fortnight or more)], and (iii) markers of socio–economic development 144 
[maternal education (low = less than O-level or equivalent; medium = O-level, and high = greater 145 
than O-level), home ownership (mortgaged/owned, privately rented or housing association/council 146 
rented/other), maternal social class based on her occupation (non-manual and manual) and 147 
crowding in the home (≤ one person or > one person per room)]. We also included two variables to 148 
control for variation in the vitamin D measurement: gestation (week) and season of sample 149 
collection [spring (March, April, and May), summer (June, July, and August) autumn (September, 150 
October, and November), and winter (December, January and February)]. While it is unlikely that 151 
the age of the child at assessment would be confounded by maternal vitamin D status, outcomes 152 
were adjusted for child age at the 6-month measurement, owing to the strong association between 153 
age and outcomes at this early life stage. 154 
 155 
We used three models to adjust the analysis for potential confounders.  As 25(OH)D measurements 156 
spanned pregnancy, and as gestational week is associated with vitamin D status(26), we do not 157 
present unadjusted data; our minimally adjusted model (Model 1) included gestational week of 158 
25(OH)D measurement. Model 2 built on Model 1 by including nine confounders associated with 159 
both vitamin D status (Table 1) and cognitive development (parity, tobacco smoking, housing 160 
status, crowding, maternal age, BMI, education, ethnic group, and social class) and two child 161 
factors (gender and breastfeeding). Model 3 included Model 2 confounders plus two variables (oily 162 
fish intake and season of vitamin D measurement) that could affect maternal vitamin D status 163 
though including these may represent an over-control. 164 
 165 
We used simulations to assess the impact of multiple comparisons. We generated 5000 datasets 166 
where 25(OH)D measurements were randomly permutated across valid observations with these 167 
data. As a consequence, all analyses maintained the same number of observations and, with all other 168 
data unchanged, the correlations between outcomes and confounders were preserved. The analyses 169 
were based upon Model 3. The effect of randomisation was to generate a set of results under the 170 
null hypothesis to which our set of observed results could be compared. A composite score across 171 
the 27 outcomes was based upon the sum of P values. These were modified to one-sided tests to 172 
allow results in the same direction to contribute consistently to the score, whether statistically 173 
significant or not. P values in the tables are not corrected for multiple comparisons. 174 
 175 
 176 
 177 
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Sensitivity analysis  178 
We conducted analyses with two additional confounders (added to Model 3) that might be on the 179 
causal pathway: preterm birth (< 37 weeks or ≥ 37 weeks) and birth weight (< 2500 g or ≥ 2500 g).  180 
We also explored the effect of including maternal iodine status in the first trimester [sufficient (≥ 181 
150 μg/g) or deficient (< 150 μg/g)] as we have previously shown that this is associated with child 182 
cognition in the ALSPAC cohort(22). As just 787 women also had a measure of iodine status in the 183 
first trimester, we used a simplified model (total of 13 confounders) to ensure that the model would 184 
converge (we dropped ethnicity and crowding in the home as a result of low numbers in the 185 
categories of those variables).  186 
 187 
As there is ongoing controversy in the published literature with respect to the definition of vitamin 188 
D deficiency(27), we conducted sensitivity analyses using a wide range of vitamin D status, namely 189 
< 25.0 and < 75.0 nmol/L as cut–offs (Supplementary Tables 3 and 4).  Assumptions concerning 190 
statistical significance were based on interpretation of confidence intervals, rather than P values, 191 
wherever possible, and multiple testing was assessed as described above. Analyses were conducted 192 
using the Statistical Package for Social Sciences (version 21·0; SPSS, Inc., Chicago, USA).  193 
 194 
Ethics 195 
The ALSPAC study was conducted according to the guidelines laid down in the Declaration of 196 
Helsinki. All procedures involving human subjects were approved by the ALSPAC Ethics and Law 197 
Committee and the Local Research Ethics Committees. Written informed consent was obtained 198 
from participants (or from their parent/guardian if under 18 years old).  199 
 200 
Role of the funding source  201 
The funding bodies did not have a role in the study design, data collection, data analysis, data 202 
interpretation, or writing of the report. The corresponding author had full access to all the study data 203 
used and final responsibility to submit for publication. 204 
 205 
Results  206 
Compared with the remainder of the ALSPAC cohort (defined as mother-singleton child pairs from 207 
the core sample surviving to one year), the mother-child pairs in this study were more likely to be 208 
older, of white ethnicity, with markers of higher socio-economic status [e.g. a higher proportion of 209 
breast-feeding mothers, higher educational attainment and social class, and a lower proportion of 210 
smokers (Supplementary Table 1)].  However, some of the actual differences were small (e.g. 211 
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maternal age 28.3 (4.8) vs. 27.7 (4.7) years). The median (IQR) 25(OH)D concentration for all 7065 212 
women with a child that had at least one relevant outcome was 61.3 (42.9 – 84.7) nmol/L, with 213 
4.4% having < 25.0 nmol/L, 34.6% having < 50.0 nmol/L and 65.7% having < 75.0 nmol/L. 214 
 215 
The median (IQR) gestational week of vitamin D measurement (available for 7064 women) was 216 
29.6 (12.7, 33.3) weeks, with 26.1% in the first trimester (≤ 13 weeks), 11.8% in the second 217 
trimester (14 – 27 weeks) and 62.1% in the third trimester (≥ 28 weeks). The median (IQR) 218 
25(OH)D measurement was 54.9 (40.1 - 72.5) nmol/L in the first trimester, 59.3 (38.6 - 84.2) 219 
nmol/L in the second trimester and 65.3 (45.2 - 90.4) nmol/L in the third trimester. Table 1 shows 220 
the confounders associated with maternal vitamin D status using the 50 nmol/L cut-off. Women 221 
with 25(OH)D concentration ≥ 50.0 nmol/L were more likely to be white, older, and have markers 222 
of higher socio-economic status (for example education, home ownership and reduced smoking and 223 
crowding).  224 
 225 
Results of logistic regression models using the cut-off value for serum 25(OH)D of <50.0 nmol/L to 226 
define deficiency are shown in Table 2. In the minimally adjusted analysis (Model 1), the only 227 
outcomes associated with vitamin D status were verbal IQ at 8 years and words read per minute at 228 
age 9 (Table 2).  However, after adjustment for potential confounders, the effect on IQ and reading 229 
was attenuated and the only outcomes that remained statistically significant were gross- and fine-230 
motor development at 30 months and social development at 42 months. With further adjustment for 231 
oily-fish intake and season (Model 3), the association between maternal vitamin D status and gross-232 
motor development also became significant at 18 months, while remaining associated with gross-233 
motor and fine-motor development at 30 months and social development at 42 months (Table 2). 234 
Children born to mothers with 25(OH)D  ≤ 50.0 nmol/L were more likely to have scores in the 235 
bottom quartile for these variables.  236 
 237 
For the ALSPAC pre-school development assessments, when the serum 25(OH)D of < 50.0 nmol/L 238 
group was divided into < 25.0 and 25.0 – 49.9 nmol/L, there was evidence of a statistically 239 
significant trend to decreasing risk of suboptimal development with higher maternal 25(OH)D 240 
concentration for gross-motor skills at 18 (P=0.02) and 30 months (P=0.008), fine-motor skills at 30 241 
months (P=0.01) and social development at 42 months (P=0.02), after adjustment for all 12 242 
confounders in Model 3 (Table 3). The effect sizes were larger for odds of suboptimal development 243 
in children of mothers in the serum 25(OH)D < 25.0 nmol/L group, than for the serum 25(OH)D of 244 
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25.0 – 49.9 nmol/L group (with the ≥ 50.0 nmol/L group as the comparison group) for all outcomes 245 
except fine-motor development at 18 months and social development at 30 months. 246 
 247 
The interaction between gestational week of 25(OH)D measurement and the vitamin D  variable 248 
(i.e. deficient vs. sufficient status) was significant for only two of 27 outcomes: fine-motor skills at 249 
30 months and performance IQ (Table 4). However, when the analysis was restricted to the 250 
ALSPAC pre-school development assessments and was split into early (≤22 weeks) and late 251 
gestation (> 22 weeks), the results suggested that the effect of deficient vs. sufficient vitamin D 252 
status on the majority of tests was greater in the second half of gestation. The effect sizes were 253 
generally larger in the second half of gestation and results were significant (Table 4) for gross motor 254 
development at 18 months (Odds Ratio (OR) 0.97, 95% CI 0.76, 1.23  vs. OR 1.31, 95% 1.08, 1.58) 255 
and 30 months (OR 1.07, 95% CI 0.84,1.38  vs OR 1.28, 95% CI 1.05,1.57), fine motor 256 
development at 30 months (0.99, 95%CI 0.76,1.29  vs OR. 1.37,  95% CI 1.12,1.67) and social 257 
development at 42 months (OR 1.07, 95% CI 0.82,1.41 vs. OR 1.28, 95% CI 1.03,1.58). There were 258 
no significant associations in either half of gestation for other neurodevelopmental outcomes, 259 
including the SDQ, IQ or reading ability (Table 4). 260 
 261 
Multiple comparisons 262 
While only 4 results in Table 2 were nominally significant at the 5% level, it was noted that 25 of 263 
the 27 results in Model 3 showed a detrimental effect for low vitamin D status. Such a result would 264 
be highly significant (p<0.0001) if the outcomes were independent. In practice, outcomes were 265 
correlated with an average r = 0.12 (range –0.03 to 0.69). The impact of these correlations was 266 
assessed using simulations. The scores from the 5000 simulated datasets had a mean (SD) of 13.52 267 
(2.78). This compared to an expected mean (SD) of 13.5 (1.5) if all the outcomes had been 268 
independent. The observed results had a score of 6.93 suggesting an empirical two-tail P value of 269 
0.016. Sequential analyses by removing those outcomes with the strongest association from the 270 
simulated scores suggested that three outcomes (gross and fine motor development at 30 months 271 
and social development at 42 months) had robust associations with the other 24 outcomes having 272 
associations consistent with chance (p=0.051). 273 
 274 
We also explored defining the score based upon the logit transformation, ln(p/(1-p)). Using this 275 
definition, the score more closely approximated to a normal distribution. However this did not 276 
change the conclusions. 277 
 278 
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Sensitivity analysis 279 
When we added the variables, preterm birth and birth weight, to Model 3, the results were 280 
fundamentally unchanged (Supplementary Table 2), though the effect of maternal vitamin D status 281 
on gross motor development at 18 months and social development at 42 months was no longer 282 
statistically significant. 283 
 284 
The addition of suboptimal iodine-to-creatinine ratio in the first trimester to Model 3 resulted in 285 
considerable sample attrition given the low number of women with iodine measurements (n=787) 286 
(Supplementary Table 2). Though the effect sizes were larger than previously, the associations 287 
between maternal vitamin D and gross motor development at 18 and 30 months and social 288 
development at 42 months were no longer significant, though they remained significant for fine 289 
motor development at 18 (OR 1.50, 95% CI 1.02, 2.23) and 30 months (OR 1.61, 95% CI 1.06, 290 
2.46). 291 
 292 
We explored whether dichotomising women according to different 25(OH)D cut-offs (25.0 or 75.0 293 
nmol/L) changed the results (Supplementary Tables 3 and 4), bearing in mind the lower relative 294 
statistical power that results when the cut-off leads to unequal numbers in each group (the 50.0 295 
nmol/L cut-off was close to the median 25(OH)D concentration of 54.9 nmol/L). When using the 296 
25.0 nmol/L cut-off, the only outcome associated with vitamin D deficiency in the fully adjusted 297 
model was gross motor development at 30 months (OR 1.43 95% CI 1.01-2.02); results approached 298 
statistical significance for other outcomes (e.g. social development at 42 months, OR 1.40 95% CI 299 
0.97-2.02; Supplementary Table 3). Using a cut-off of 75.0 nmol/L to define deficiency resulted in 300 
null associations with the ALSPAC pre-school development assessments, behaviour and cognitive 301 
tests, but was associated with higher odds of sub-optimal reading accuracy at 9 years (OR 1.26 95% 302 
CI 1.01, 1.57); however, this may be a chance finding as reading accuracy was not associated with 303 
vitamin D in any other analyses (Tables 2, 3 and 4 and Supplementary Tables 2 and 3).    304 
 305 
Discussion  306 
After adjustment for potential confounders, children born to vitamin-D deficient mothers (serum 307 
25(OH)D of <50.0 nmol/L) were more likely to have sub-optimal gross-motor skills at 30 months, 308 
sub-optimal fine-motor skills at 30 months and sub-optimal social development scores at 42 months 309 
than were children born to sufficient mothers (≥50.0 nmol/L).  Although the effect sizes were 310 
relatively small, we consider that the findings were biologically meaningful.  Interestingly, no 311 
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associations were found between maternal vitamin D status and other outcomes (IQ, reading 312 
ability).   313 
 314 
These results suggest that the vitamin D content of seafood might explain some of the beneficial 315 
effects of maternal seafood consumption seen previously in ALSPAC, at least for fine-motor skills 316 
at 30 months and social skills at 42 months(1). The classification of maternal seafood consumption 317 
by Hibbeln et al.(1) included white fish and shellfish which are not good sources of dietary vitamin 318 
D, therefore, we would not expect vitamin D intake to account totally for their findings. 319 
Furthermore, our results cannot explain previous associations found in ALSPAC between maternal 320 
seafood consumption and IQ(1) or between maternal iodine status and IQ and reading ability(22). 321 
 322 
Our findings on fine- and gross-motor skills support previous non-ALSPAC-based research that 323 
found a positive association between maternal vitamin D status and infant psychomotor 324 
development(11).  Although we did not specifically measure scholastic achievement, the lack of an 325 
association between maternal vitamin D status and either reading ability or IQ in our study 326 
reinforces the findings of a previous study that found no relationship between maternal 25(OH)D 327 
status and offspring scholastic achievement(10).  While a US study found a relationship between 328 
maternal vitamin D status and offspring IQ, the effect estimates were very small and there was very 329 
little indication of an association between maternal blood 25(OH)D and cognitive development, 330 
achievement, or behaviour between 8 months and 7 years of age(12).   331 
 332 
Our findings suggest that some specific aspects of early neurocognitive development may be 333 
suboptimal if maternal prenatal vitamin D is deficient (i.e. serum 25(OH)D of < 50.0 nmol/L) in 334 
pregnancy. The biological mechanism underpinning this association in humans is not fully 335 
understood, but the ubiquitous presence of the vitamin D receptor (VDR) and the hydroxylase 336 
enzymes controlling vitamin D metabolism in a wide variety of areas of the human brain(6), as well 337 
as neurological developmental mechanisms previously identified in studies of vitamin D deficiency 338 
in pregnant rats may be relevant(7; 9; 28; 29).   These include enlarged brain ventricles, thinner 339 
neocortex(29), and more mitotic cells in the brain(29), suggesting a less differentiated phenotype(28).  340 
The active form of vitamin D [1,25(OH)2D], may also affect the development of the brain by 341 
influencing the production of cytokines(30), affecting neurotransmission(31) and synaptic plasticity(31) 342 
which is likely to affect learning processes(32) and therefore neurocognitive development.  343 
1,25(OH)2D likely affects dopamine activity in the brain owing to the presence of the vitamin D 344 
receptor (VDR) in brain areas responsive to dopamine(33). Ventral midbrain dopaminergic neurones 345 
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are known to play a key role in the modulation of motor behaviour(34). It is therefore feasible that 346 
1,25(OH)2D may affect motor development via its effects on the dopaminergic system. Other 347 
potential mechanisms may relate to an association between maternal 25(OH)D status and fetal 348 
growth retardation (e.g. reduced fetal head size) which is associated with later developmental 349 
disabilities(35).  A recent study in the Generation R cohort in the Netherlands found an association 350 
between lower maternal 25(OH)D status at 20 weeks gestation and smaller fetal-head circumference 351 
in the third trimester(36), suggesting that poorer maternal 25(OH)D status may predispose children to 352 
developmental delay via effects on intra-uterine growth restriction. 353 
 354 
When we assessed the impact of gestational age on our results for outcomes that were significantly 355 
associated with vitamin D in the main analyses, we found that the effect sizes were generally 356 
greater when vitamin D was measured in the second half (> 22 weeks) than in the first half (≤ 22 357 
weeks) of pregnancy. There is a small amount of evidence in rats that re-introduction of vitamin D 358 
after birth, but before end of weaning, can rescue normal brain development(28); that time period 359 
correspond to the third trimester in humans, suggesting a potential crucial window for vitamin D in 360 
brain development. However, all interpretations in our analysis of gestational timing need to be 361 
interpreted in light of the fact that we only had one measurement of maternal vitamin D status for 362 
each woman and so we cannot draw clear conclusions on the effects of gestational timing of vitamin 363 
D deficiency. Furthermore, we cannot be sure that our observed effects are confined to the 364 
gestational week that the 25(OH)D measurement was made, as some individuals may have 365 
persistent pattern of vitamin D status that extends into later pregnancy or infancy.   366 
 367 
When the women were split into three groups [serum 25(OH)D of  <25.0, 25.0 – 49.9 and  ≥ 50.0 368 
nmol/L], adverse outcomes were present in the offspring of mothers with insufficient status (serum 369 
25(OH)D < 50nmol/L) as well as those with severe deficiency (serum 25(OH)D < 25nmol/L). 370 
However, there was a trend to larger effect sizes in the more deficient < 25.0 nmol/L group than in 371 
the 25.0 – 49.9 nmol/L group; the relatively small sample size in the < 25.0 nmol/L group explains 372 
the wider confidence intervals seen for this cut-off.  The outcomes that were significantly associated 373 
with vitamin D when women were dichotomised on the basis of a cut-off of 50.0 nmol/L were not 374 
significant when the cut-off was increased to 75.0 nmol/L.  These findings support a vitamin D 375 
status cut-off for optimal child outcomes closer to 50.0 nmol/L than to 75.0 nmol/L.  376 
 377 
As the women in the ALSPAC study were recruited over 20 years ago, we compared their vitamin 378 
D status to more recent measurements in UK women to assess the current relevance of our findings. 379 
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As 25(OH)D status  does not differ between pregnant and non–pregnant women(15) we looked at 380 
nationally representative data in UK women from the recent National Diet and Nutrition Survey 381 
(NDNS).  In the latest report (sampling 2008/9 – 2011/12), 21.7% of women of 19–64 years had a 382 
plasma 25(OH)D concentration below 25 nmol/L(37), a higher percentage than the 4.4% of women 383 
in ALSPAC. Other studies(38; 39), including those in pregnancy, suggest that many UK women are 384 
vitamin D deficient. Currently, the UK National Institute for Health and Care Excellence (NICE) 385 
recommends that pregnant women should take a supplement of 10 µg (400 IU) of vitamin D per 386 
day(40). However use of vitamin D supplements in pregnancy is low, with a recent survey (2005–387 
2009) finding that only 1.4% of UK pregnant women had taken a vitamin D supplement(41). Our 388 
findings give further evidence that public-health campaigns should address the vitamin D status of 389 
UK pregnant women, and encourage compliance with the 10 µg/d recommendation(40).   390 
 391 
Strengths and Limitations 392 
Although our study has several strengths, including the large sample size, there are also limitations. 393 
Firstly each woman had only one measure of maternal vitamin D status in pregnancy which may not 394 
have reflected status over the whole of pregnancy. In addition, the range of vitamin D status in the 395 
ALSPAC women was limited, with approximately one third (34.6%) having a 25(OH)D 396 
concentration less than 50.0 nmol/L and only a small proportion having a 25(OH)D concentration 397 
less than 25.0 nmol/L (4.4%). Moreover, ALSPAC only has a relatively small number of women 398 
from ethnic-minority backgrounds (just 2% of this study sample), who are known to be at particular 399 
risk of having low 25(OH)D concentrations(42), suggesting that the results may differ in populations 400 
with a larger number of ethnic-minority individuals. Finally, we were not able to control for the 401 
association between infant vitamin D status and neurocognitive function as we had no measures of 402 
vitamin D status in infancy.  Infant vitamin D status may partly explain some of the association seen 403 
in this paper between maternal vitamin D status and infant neurodevelopment. 404 
 405 
In conclusion, we found that maternal vitamin D status in pregnancy was associated with a number 406 
of adverse neurocognitive developmental variables in early childhood, albeit with a small, but 407 
nonetheless important, effect size. There is a need for replication of this work in other settings to 408 
confirm these results, but the public-health implications of these findings are nevertheless 409 
potentially important.  Further study is now urgently required, particularly in population groups that 410 
are more severely vitamin D deficient such as dark-skinned ethnic-minority women37 who may 411 
show a wider range and greater severity of sub-optimal neurocognitive outcomes.   412 
 413 
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Table 1 Relationship between confounders and maternal Vitamin D status 
Confounder Maternal vitamin D status 
< 50.0 nmol/L ≥ 50.0 nmol/L  
Mean SD n Mean SD n p value† 
        
Age of mother (yrs) 27.7  4.8 2443 28.6 4.7 4622 < 0·0001 
BMI of mother (Kg/m2) 23.0  4.0 2126 22.9 3.6 4095 0.43 
Gestation of vitamin D measure 
(weeks) 
23.4  10.9 2771 25.7  10.3 5174 < 0·0001 
 
 % n  % n  p value ‡ 
Breastfeeding 
Some 33·0% 1738  67·0% 3526  < 0·0001 
None 38·8% 553  61·2% 874  
Crowding in the home 
< one person per room 33·9% 2140  66·1% 4170  < 0·0001 
One or more per room 43.6% 176  56·4% 228  
Education of mother 
Low 37·5% 716  62·5%  1195  < 0·0001 
Medium 33·4% 792  66·6% 1577  
High 31·5% 755  68·5% 1643  
Ethnicity of mother 
White 33·3% 2171  66·7% 4344  < 0·0001 
Non–white 60·6% 83  39·4% 54  
Gender of child 
Male 34·3% 1266  65·7% 2421  0·67 
Female 34·8% 1177  65·2% 2201  
Housing status 
Owned/mortgaged 32·8% 1705  67·2% 3487  < 0·0001 
Other rented 36·6% 150  63·4% 260  
Council rented 41·0% 491  59·0% 708  
Iodine–to–creatinine ratio in 1st trimester 
<150 μg/g (deficient) 33.5% 186  66.5% 374  0.94 
≥150 μg/g (sufficient) 33.2% 76  66.8% 151  
Oily fish intake in pregnancy (/week) 
Never/rarely 37·7% 1038  62·3% 1718  < 0·0001 
Once per fortnight or more 31·3% 1191  68·7% 2617  
Parity 
Zero 37·0% 1125  63·0% 1914  < 0·0001 
One or more 31·9% 1179  68·1% 2516  
Season of vitamin D measure        
Spring 48.8% 980  51.2% 1027  < 0·0001 
Summer 15.2% 268  84.8% 1491  
Autumn 22.4% 363  77.6% 1257  
Winter 49.5% 831  50.5% 847  
Smoking in 1st trimester 
No tobacco  31·7% 1652  68·3% 3567  < 0·0001 
Smoked tobacco 42·5% 689  57·5% 932  
Social class of mother 
Manual 36·6% 383  63·4% 664  0·01 
Non–manual 32·5% 1447  67·5% 3008  
† p value from independent t-test.  
‡p value for χ2 test.
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Table 2 Odds of suboptimal outcomes according to maternal vitamin D status (< 50.0 vs ≥ 50.0 nmol/L), minimally and fully adjusted for 
potential confounders 
   Model 1† Model 2‡ Model 3§ 
  Age OR (95% CI) p value n OR (95% CI) p value n OR (95% CI) p value n 
ALSPAC 
pre–school 
development 
assessments 
Gross Motor 
Skills 
6 mo ‖ 0.96 (0.84, 1.09) 0.49 6242 1.01 (0.86, 1.18) 0.92 4383 0.96 (0.81, 1.13) 0.59 4380 
18 mo 0.98 (0.87, 1.10) 0.74 6269 1.10 (0.96, 1.27) 0.18 4385 1.17 (1.01, 1.36) 0.04 4383 
30 mo 1.02 (0.91, 1.16) 0.71 5843 1.16 (1.00, 1.34) 0.05 4135 1.20 (1.03, 1.40) 0.02 4133 
42 mo 0.99 (0.87, 1.13) 0.89 5695 1.04 (0.89, 1.22) 0.60 4073 1.09 (0.92, 1.28) 0.31 4070 
Fine Motor 
Skills 
6 mo ‖ 0.93 (0.82, 1.05) 0.24 5880 1.07 (0.92, 1.25) 0.39 4141 1.06 (0.91, 1.25) 0.47 4139 
18 mo 1.07 (0.96, 1.21) 0.24 6268 1.03 (0.90, 1.19) 0.65 4383 1.09 (0.94, 1.27) 0.26 4381 
30 mo 1.09 (0.96, 1.23) 0.18 5854 1.20 (1.04, 1.40) 0.02 4138 1.23 (1.05, 1.44) 0.01 4136 
42 mo 1.04 (0.92, 1.19) 0.51 5692 1.11 (0.95, 1.31) 0.19 4071 1.16 (0.98, 1.37) 0.08 4068 
Social 
Development  
6 mo ‖ 0.96 (0.84, 1.09) 0.52 6010 1.02 (0.87, 1.19) 0.81 4209 1.00 (0.85, 1.18) 0.98 4207 
18 mo 1.01 (0.89, 1.15) 0.86 6268 1.10 (0.94, 1.28) 0.22 4383 1.14 (0.97, 1.34) 0.11 4381 
30 mo 0.97 (0.86, 1.10) 0.64 5843 1.11 (0.95, 1.30) 0.18 4129 1.07 (0.91, 1.27) 0.42 4127 
42 mo 1.04 (0.92, 1.18) 0.54 5689 1.19 (1.02, 1.39) 0.03 4069 1.20 (1.01, 1.41) 0.04 4066 
Communication  6 mo ‖ 0.99 (0.85, 1.15) 0.90 6100 0.99 (0.83, 1.20) 0.95 4285 0.99 (0.81, 1.20) 0.90 4283 
18 mo 0.99 (0.87, 1.12) 0.85 6279 1.11 (0.96, 1.29) 0.17 4390 1.12 (0.95, 1.31) 0.18 4388 
Behaviour Prosocial 7 yr 0.92 (0.75, 1.13) 0.40 4791 0.97 (0.75, 1.24) 0.78 3513 1.00 (0.77, 1.31) 0.98 3511 
Peer problems 7 yr 1.05 (0.88, 1.25) 0.58 4785 1.03 (0.83, 1.27) 0.80 3510 1.05 (0.83, 1.31) 0.70 3508 
Hyperactivity 7 yr 1.06 (0.91, 1.24) 0.47 4780 1.04 (0.86, 1.26)  0.68 3513 1.04 (0.85, 1.26) 0.74 3511 
Emotional 7 yr 1.17 (0.98, 1.41) 0.09 4785 1.14 (0.92, 1.42) 0.23 3511 1.20 (0.95, 1.51) 0.12 3509 
Conduct 7 yr 1.13 (0.99, 1.30) 0.08 4790 1.05 (0.88, 1.24) 0.60 3514 1.06 (0.89, 1.27) 0.50 3512 
Total Score 7 yr 1.08 (089, 1.32) 0.42 4777 1.13 (0.89, 1.44) 0.31 3510 1.24 (0.96, 1.60)  0.09 3508 
Cognition Verbal IQ 8 yr 1.19 (1.02, 1.39) 0.03 3997 1.08 (0.89, 1.31) 0.47 2952 1.00 (0.82, 1.23) 0.98 2950 
Performance IQ 8 yr 1.06 (0.91, 1.24) 0.43 3990 0.99 (0.82, 1.20) 0.92 2945 1.00 (0.82, 1.23) 0.98 2943 
Total IQ 8 yr 1.16 (1.00, 1.35) 0.06 3978 1.02 (0.84, 1.24) 0.82 2938 1.01 (0.82, 1.24) 0.93 2936 
Reading 
ability 
Words per min 9 yr 1.17 (1.00, 1.36) 0.05 3794 1.14 (0.94, 1.39) 0.18 2763 1.15 (0.94, 1.42) 0.17 2761 
Accuracy 9 yr 1.16 (0.99, 1.35) 0.07 3802 1.04 (0.85, 1.28) 0.69 2767 1.03 (0.83, 1.27) 0.80 2765 
Comprehension  9 yr 1.11 (0.95, 1.30) 0.18 3802 1.02 (0.83, 1.25) 0.87 2767 1.04 (0.84, 1.29) 0.73 2765 
Reading Score  9 yr 1.10 (0.95, 1.27) 0.22 4125 1.06 (0.88, 1.27) 0.54 3028 1.04 (0.86, 1.26) 0.69 3026 
mo, month; OR, odds ratio; n, number of subjects; yr, years. Suboptimal outcome defined as scores in the bottom quartile for ALSPAC pre–school development assessments, cognition, and reading ability. Published cut-offs(17) 
were used for behaviour: Prosocial (≤5; 9·8%), Peer problems (≥3; 13·5%), hyperactivity (≥6; 18·7%), emotional symptoms (≥4; 12·2%), conduct problems (≥3; 24·3%), and total score (≥14; 10·5%). Maternal vitamin D status  
>50.0 nmol/L was the reference group. †Model 1 adjusted for gestational week of vitamin D measurement; ‡Model 2: gestational week of vitamin D measurement plus additional 11 variables: maternal age, maternal BMI, 
maternal ethnic group, maternal education, maternal social class, parity, tobacco smoking in 1st trimester, home ownership status, crowding index, child gender, breastfeeding; §Model 3: additionally adjusted for oily fish and 
season of vitamin D measurement; ‖ age of child at development test included in all models. 
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Table 3 Odds of suboptimal outcomes in offspring according to maternal vitamin D status when the < 50.0 nmol/L group is split into < 25.0 
and 25.0 – 49.9 nmol/L and each group is compared to ≥ 50.0 nmol/L (adjusted model 3).   
   Maternal vitamin D status (nmol/L) 
   < 25.0 vs. ≥ 50.0 25.0 – 49.9 vs. ≥ 50.0 Trend 
  OR (95% CI) n OR (95% CI) n p value  n 
ALSPAC pre–
school 
development 
assessments 
Gross Motor 
Skills 
6 mo† 1.30 (0.90, 1.88) 169 0.92 (0.77, 1.09) 1279 0.88 4380 
18 mo 1.40 (1.00, 1.96) 178 1.14 (0.98, 1.33) 1270 0.02 4383 
30 mo 1.52 (1.07, 2.17) 163 1.17 (0.99, 1.37) 1213 0.008 4133 
42 mo 1.24 (0.85, 1.82) 159 1.07 (0.90, 1.27) 1191 0.23 4070 
Fine Motor 
Skills 
6 mo† 1.24 (0.85, 1.80) 167 1.04 (0.88, 1.24) 1213 0.32 4139 
18 mo 1.03 (0.72, 1.47) 177 1.10 (0.94, 1.29) 1269 0.36 4381 
30 mo 1.30 (0.91, 1.88) 163 1.22 (1.04, 1.44) 1214 0.01 4136 
42 mo 1.31 (0.89, 1.92) 158 1.14 (0.96, 1.36) 1191 0.06 4068 
Social 
Development  
6 mo† 1.02 (0.70, 1.50) 170 1.00 (0.84, 1.19) 1216 0.95 4207 
18 mo 1.28 (0.88, 1.85) 177 1.12 (0.95, 1.33) 1269 0.08 4381 
30 mo 0.91 (0.61, 1.36) 163 1.09 (0.92, 1.30) 1212 0.66 4127 
42 mo 1.49 (1.02, 2.18) 158 1.16 (0.98, 1.38) 1190 0.02 4066 
Communication 6 mo† 1.41 (0.93, 2.14) 167 0.94 (0.77, 1.16) 1237 0.59 4283 
 18 mo 1.31 (0.92, 1.88)  179 1.09 (0.93, 1.29) 1272 0.11 4388 
Behaviour Prosocial 7 yr 1.11 (0.59, 2.09)  124 0.99 (0.75, 1.30) 1003 0.89 3511 
Peer problems 7 yr 0.97 (0.56, 1.67) 124 1.05 (0.84, 1.33) 1002 0.80 3508 
Hyperactivity 7 yr 0.63 (0.37, 1.08) 124 1.09 (0.89, 1.33) 1002 0.70 3511 
Emotional 7 yr 0.80 (0.43, 1.49) 124 1.25 (0.99, 1.57) 1002 0.34 3509 
Conduct 7 yr 0.80 (0.50, 1.27) 124 1.10 (0.91, 1.32) 1003 0.88 3512 
Total Score 7 yr 0.68 (0.33, 1.39) 124 1.31 (1.02, 1.70) 1001 0.37 3508 
Cognition Verbal IQ 8 yr 1.07 (0.67, 1.73) 103 0.99 (0.80, 1.23) 839 0.90 2950 
 Performance IQ 8 yr 1.40 (0.89, 2.20) 104 0.96 (0.78, 1.18) 837 0.56 2943 
 Total IQ 8 yr 1.37 (0.87, 2.17) 103 0.97 (0.78, 1.20) 834 0.54 2936 
Reading ability Words per min 9 yr 1.11 (0.68, 1.80) 101 1.16 (0.94, 1.43) 797 0.23 2761 
Accuracy 9 yr 1.14 (0.70, 1.87) 101 1.02 (0.81, 1.27) 799 0.69 2765 
Comprehension 9 yr 1.01 (0.61, 1.66) 101 1.04 (0.84, 1.30) 799 0.78 2765 
Reading Score  9 yr 0.91 (0.57, 1.45) 108 1.06 (0.87, 1.29) 872 0.88 3026 
mo, month; OR, odds ratio; n, number of subjects; yr, years. Suboptimal outcome defined as scores in the bottom quartile for ALSPAC pre–school development assessments, cognition, and reading 
ability. Published cut-offs(17) were used for behaviour: Prosocial (≤5; 9·8%), Peer problems (≥3; 13·5%), hyperactivity (≥6; 18·7%), emotional symptoms (≥4; 12·2%), conduct problems (≥3; 24·3%), 
and total score (≥14; 10·5%). Maternal vitamin D status ≥ 50.0 nmol/L was the reference group. †age of child at development test included in all models.              
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Table 4 Odds of suboptimal outcomes in offspring by maternal vitamin D status (< 50.0 vs ≥ 50.0 nmol/L) according to whether maternal 
vitamin D was measured in the first or second half of gestation (Adjusted Model 3) 
   First half of gestation (≤ 22 weeks) Second half of gestation (> 22 weeks) P value for interaction* 
   OR (95% CI) P value n OR (95% CI) P value n  
ALSPAC 
pre–school 
development 
assessments 
Gross Motor 
Skills 
6 mo† 0.92 (0. 70, 1.22) 0.56 1500 0.98 (0.79, 1.21) 0.84 2880 0.21 
18 mo 0.97 (0.76, 1.23) 0.78 1522 1.31 (1.08, 1.58) 0.005 2861 0.13 
30 mo 1.07 (0.84, 1.38) 0.58 1435 1.28 (1.05, 1.57) 0.02  2698 0.79 
42 mo 1.03 (0.79, 1.34) 0.85 1422 1.10 (0.89, 1.36) 0.37 2648 0.72 
Fine Motor 
Skills 
6 mo† 1.09 (0.83, 1.44) 0.52 1436 1.03 (0.83, 1.27) 0.80 2703 0.25 
18 mo 1.05 (0.82, 1.36) 0.69 1522 1.10 (0.90, 1.33) 0.35 2859 0.46 
30 mo 0.99  (0.76, 1.29) 0.95 1436 1.37 (1.12, 1.67) 0.002  2700 0.05 
42 mo 1.03 (0.78, 1.37) 0.83 1420 1.24 (1.00, 1.53) 0.05 2648 0.37 
Social 
Development  
6 mo† 0.88 (0.66, 1.16) 0.37 1453 1.11 (0.90, 1.38) 0.32 2754 0.90 
18 mo 1.23 (0.95, 1.60) 0.12 1522 1.07 (0.87, 1.32) 0.51 2859 0.11 
30 mo 0.96 (0.74, 1.26) 0.79 1431 1.13 (0.91, 1.40) 0.28 2696 0.36 
42 mo 1.07 (0.82, 1.41) 0.62 1420 1.28 (1.03, 1.58) 0.02 2646 0.26 
Communication 6 mo† 0.90 (0.65, 1.23) 0.50 1468 1.04 (0.81, 1.34) 0.75  2815 0.37 
 18 mo 1.27 (0.98, 1.65) 0.07 1524 1.04 (0.85, 1.28) 0.71 2864 0.17 
Behaviour Prosocial‡ 7 yr 0.75 (0.48, 1.17)  0.21 1216 1.15 (0.83, 1.61)  0.40 2301 0.10 
Peer problems 7 yr 1.14 (0.78, 1.66) 0.49 1210 0.97 (0.73, 1.30) 0.86 2298 0.55 
Hyperactivity 7 yr 0.95 (0.68, 1.33) 0.75 1213 1.10 (0.86, 1.41) 0.46 2298 0.31 
Emotional‡ 7 yr 1.25 (0.87, 1.80) 0.23 1214 1.17 (0.87, 1.58)  0.29 2301 0.71 
Conduct 7 yr 1.13 (0.84, 1.52) 0.42 1212 1.04 (0.82, 1.31) 0.74 2300 0.76 
Total Score‡ 7 yr 1.20 (0.79, 1.82) 0.40 1214 1.24 (0.90, 1.71)  0.18 2300 0.79 
Cognition Verbal IQ 8 yr 1.09 (0.77, 1.55) 0.64 1025 0.93 (0.72, 1.21) 0.60 1925 0.20 
 Performance IQ 8 yr 1.15 (0.83, 1.59) 0.42 1017 0.89 (0.68, 1.16) 0.38 1926 0.03 
 Total IQ 8 yr 1.18 (0.84, 1.66) 0.33 1015 0.90 (0.69, 1.17) 0.43 1921 0.13 
Reading 
ability 
Words per min 9 yr 1.41 (1.00, 1.97) 0.05 936 1.00 (0.77, 1.31) 0.98 1825 0.20 
Accuracy 9 yr 1.31 (0.92, 1.87) 0.13 938 0.87 (0.66, 1.14) 0.32 1827 0.06 
Comprehension 9 yr 1.09 (0.77, 1.55) 0.62 938 0.98 (0.75, 1.29) 0.89 1827 0.31 
Reading Score  9 yr 1.30 (0.94, 1.78) 0.11 1060 0.91 (0.71, 1.16) 0.44 1966 0.20 
mo, month; OR, odds ratio; n, number of subjects; yr, years. Suboptimal outcome defined as scores in the bottom quartile for ALSPAC pre–school development assessments, cognition, and reading ability. Published cut-offs(17) 
were used for behaviour: Prosocial (≤5; 9·8%), Peer problems (≥3; 13·5%), hyperactivity (≥6; 18·7%), emotional symptoms (≥4; 12·2%), conduct problems (≥3; 24·3%), and total score (≥14; 10·5%). Maternal vitamin D status 
≥ 50.0 nmol/L was the reference group and Model 3 was used (without gestational week of vitamin D assessment as this was used to split analyses). *interaction between vitamin D (deficient/sufficient) and gestational week of 
sample (continuous variable); †age of child at development test included in all models; ‡ethnicity removed as model would not converge. 
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Legends for Figures 
Figure 1: Flow of participants  
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